CYTOKINETICS INC 4

Insider Lynne B. Parshall sold 5,000 shares of Cytokinetics, Inc. common stock at $71.48 per share on 2026-09-01.

On 2026-09-01, reporting person Lynne B. Parshall executed an open market sale of 5,000 shares of Cytokinetics, Inc. common stock at a reported price of $71.48 per share, for total proceeds of approximately $357,400. Following this transaction, Parshall's direct ownership decreased to 10,784 shares of common stock, with an implied post-transaction holding value of roughly $770,000 based on the same transaction price. The sale was reported on Form 4 and filed on 2026-09-01, with the form signed by attorney-in-fact John O. Faurescu on behalf of Ms. Parshall.

Filing Facts

CIK

1061983

Ticker

CYTK

Form

4

Source Type

fda

Accession

0001061983-26-000091

Alert Tier

6